Новости мировой тиреоидологии

1. Turkkahraman D., Alper O.M., Aydin F. et al. Final diagnosis in children with subclinical hypothyroidism and mutation analysis of the thyroid peroxidase gene (TPO) // J. Pediatr. Endocrinol. Metab. 2009. V. 22(9). P. 845–851.

2. Lifante J.C., McGill J., Murry T., Aviv J.E., Inabnet W.B. A prospective, randomized trial of nerve monitoring of the external branch of the superior laryngeal nerve during thyroidectomy under local/regional anesthesia and IV sedation // Surg. 2009. V. 146(6). P. 1167–1173.

3. Stevens C., Lee J.K., Sadatsafavi M., Blair G.K. Pediatric thyroid fine-needle aspiration cytology: a metaanalysis // J. Pediatr. Surg. 2009. V. 44(11). P. 2184–291.

4. Levine R.J., Vatten L.J., Horowitz G.L. et al. Preeclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study // B.M.J. 2009. V. 17.

5. Kara M., Tellioglu G., Krand O. et al. Predictors of hypocalcemia occurring after a total/near total thyroidectomy // Surg. Today. 2009. V. 39(9). P. 752–757.

6. Ribault V., Castanet M., Bertrand A.M. et al. Experience with intraamniotic thyroxine treatment in nonimmune fetal goitrous hypothyroidism in 12 cases // J. Clin. Endocrinol. Metab. 2009. V. 94(10). P. 3731–3739.

7. Träisk F., Tallstedt L., Abraham-Nordling M. et al. Thyroid-associated ophthalmopathy after treatment for Graves’ hyperthyroidism with antithyroid drugs or iodine131 // J. Clin. Endocrinol. Metab. 2009. V. 94(10). P. 3700–3077.

8. Bhargav P.R., Mishra A., Agarwal G. et al. Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome // Wld J. Surg. 2009. V. 33(10). P. 2087–2093.

9. Ayturk S., Gursoy A., Kut A. et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area // Eur. J. Endocrinol. 2009. V. 161(4). P. 599–605.

10. Bach-Huynh T.G., Nayak B. Loh J. et al. Timing of levothyroxine administration affects serum thyrotropin concentration // J. Clin. Endocrinol. Metab. 2009. V. 94(10). P. 3905–3912.

11. Shie P., Cardarelli R., Sprawls K. et al. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography // Nucl. Med. Commun. 2009. V. 30(9). P. 742–748.

12. Desideri G., Bocale R., Milardi D. et al. Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant // Clin. Endocrinol. (Oxf.). 2009. V. 71(3). P. 429–433.

13. Mourits M.P., Bijl H., Altea M.A. et al. (European Group on Graves’ Orbitopathy (EUGOGO)). Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures // Br. J. Ophthalmol. 2009. V. 93(11). P. 1518–1523.

14. Nygaard B., Jensen E.W., Kvetny J. et al. Effect of combination therapy with thyroxine (T4) and 3,5,3’-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study // Eur. J. Endocrinol. 2009. V. 161(6). P. 895–902.

15. Correia N., Mullally S., Cooke G. et al. Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism // J. Clin. Endocrinol. Metab. 2009. V. 94(10). P. 3789–3797.

16. Cappelli C., Rotondi M., Pirola I. et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients // Diabetes Care. 2009. V. 32(9). P. 1589–1590.